Vertex Pharmaceuticals Has a $10 Billion Opportunity on the Table. Here's How You Can Invest Alex Carchidi, The Motley Fool Tue, Feb 6, 2024, 6:53 AM5 min read ...

Right now, Vertex's trailing-12-month revenue is $9.6 billion. Financial analysts estimate that if it gets approved, VX-548 could generate between $5 billion and $10 billion annually by 2030.